Teeling et al. reanalyzed a previously published morphological data set that included four extinct families (5), using their DNA tree as a constraint. The resulting trees placed the Eocene fossil families as sister taxa (close relatives) to the lineage leading to all living bats. Previous analyses of fossilized stomach contents, ear anatomy, and limb structure concluded that two of the fossil families were sophisticated echolocators similar to most living bats (5) . The other fossil groups are also thought to have been capable of echolocation, although they may not have been able to track flying prey (5) . Taking the relationships of these fossils into account, it seems most likely that echolocation evolved only once in bats, before diversification of the group. The lineage leading to bats was thus characterized by two remarkable specializations seen in no other land mammals: powered flight and echolocation. The coincidence of these adaptations-which may have been functionally and evolutionarily linked (9)-was probably the key that started the evolutionary diversification of the group.
The scope of this "big bang" Eocene radiation is unprecedented in mammalian history. What may have caused it? Teeling et al. speculate that bats diversified in the Early Eocene in response to an increase in prey diversity, and that the varied echolocation and flight strategies that characterize families may have evolved as a result of differential exploitation of ecological niches available at that time. The origin of the major bat lineages in the Eocene is apparently coincident with a rise in mean annual temperature, a significant increase in plant diversity, and the peak of Tertiary insect diversity (4) . The evolutionary success of bats thus may have resulted from ancestral bats being in the right place at the right time.
As flying predators capable of capturing prey on the wing, they would have had few competitors for the rich resources of the Eocene night. The only other vertebrates that exploit niches for nocturnal flying predators are the owls and nightjars. Interestingly, owls may also have undergone an adaptive radiation in the Eocene (10) .
The geographic origin of bats has been a source of debate because Eocene bat fossils have been found on most continents (5, 6) . Teeling et al. (4) seemingly have solved this problem with their new phylogeny, which unambiguously indicates a Laurasian (Northern Hemisphere) origin for bats. Once the group was established, different lineages of bats probably diversified on different continents, but the scale of the Teeling et al. analysis does not allow them to untangle these patterns. Indeed, it is the scale of bat diversity that makes this study so tantalizing. Their results give us a new framework for understanding bat evolution, but it is only the tip of the iceberg. Although broad in scope, their evolutionary tree includes fewer than 40 out of more than 1100 living bat species-just 3%. Understanding the patterns of evolution of different echolocation strategies, diets, body sizes, flight styles, and reproductive habits of bats will require much more finegrained phylogenies than are now available. As always, the devil will be in the details.
M
alaria is the scourge of many developing countries, particularly those in sub-Saharan Africa, claiming several million lives each year. Researchers have struggled for decades to make a successful subunit or attenuated whole-organism vaccine but with limited success. Factors that have hampered the development of a subunit vaccine include the complexity of the malaria life cycle, the wide variety of immune response induced by the malaria parasite, and an incomplete knowledge of protective immunity. In contrast, attenuated whole-organism vaccines are better understood and in principle should provide full protective immunity. Encouraging news in this regard comes from Mueller et al. reporting in a recent issue of Nature (1). They show that mice immunized with genetically attenuated sporozoites of the rodent malaria parasite Plasmodium berghei are completely protected against challenge with wild-type sporozoites.
A malaria infection is initiated by injection of sporozoites into the host blood by a female anopheline mosquito as she takes a blood meal (see the figure) . The sporozoite must migrate to the liver and colonize a hepatocyte (liver cell) in order for the infection to progress. This journey is hazardous, requiring traversal of resident macrophages (Kupffer cells) lining the liver's blood vessels and passage through a number of hepatocytes before the sporozoite finds a liver cell to invade (see the figure) . Here, the sporozoite differentiates, grows, and multiplies within the hepatocyte, producing thousands of merozoites that are released into the bloodstream where they invade red blood cells, initiating the erythrocytic stage of the disease.
Of the various antimalaria vaccination strategies proposed, preventing the sporozoite from infecting a hepatocyte or blocking its subsequent intracellular development has the advantage of acting before the onset of pathology that is exclusively associated with the erythrocytic stage of infection. However, "pre-erythrocytic" vaccines must be 100% effective because a single surviving sporozoite can still cause a lethal blood-stage infection. In 1967, Nussenzweig and colleagues (2) generated sterile protective immunity in a mouse model by administering whole P. berghei sporozoites that had been attenuated by gamma irradiation. These radiation-attenuated sporozoites (RAS) were incapable of infecting mice, yet when given to mice as a vaccine in a prime-boost combination, they generated long-lasting immunity to subsequent challenge with normal nonirradiated parasites. Immunity results from multifactorial responses that are thought to include sporozoite-specific antibodies, effector CD8 + and CD4 + T cells, and memory CD8 + T cells that recognize the infected hepatocyte (3, 4).
Subsequent work with the human
Plasmodium species elicited long-lasting protection (>10 months) in human volunteers in a species-specific (although strainindependent) fashion. However, volunteers had to be immunized with sufficient sporozoites (>1000) of P. falciparum (the most lethal species of human malaria parasite), which had to be delivered through the bite of an irradiated infected mosquito. Numerous logistical problems surround human vaccination with RAS. These difficulties encouraged an intensive, but so far disappointing, 25-year search for sporozoite and bloodstage antigens that could be used in a subunit vaccine (5) . Now, the tide has turned once more, and there is renewed and vigorous interest in a malaria vaccine comprising an attenuated whole parasite (6).
The Mueller et al. vaccine study resurrects the principle of RAS immunization but tosses in a twist. These investigators used genetically attenuated sporozoites (GAS) of P. berghei (7) (8) (9) , exploiting the recent availability of complete Plasmodium genome sequences. In previous work (10), Mueller et al. had used suppression subtractive cDNA hybridization to identify 29 genes whose steady-state mRNA levels were specifically elevated in infectious P. berghei sporozoites in the mosquito salivary glands. This set of genes included uis3 (up-regulated in infectious sporozoites), a small conserved transmembrane protein unique to Plasmodium. The UIS3 protein is thought to be located in micronemes, specialized apical secretory organelles that are essential for sporozoite motility and invasion of target cells. Using gene disruption (11), Mueller and colleagues generated a uis3-deficient (uis3 − ) strain of P. berghei sporozoite. The uis3 − sporozoites were motile and could invade cultured hepatocytes at wild-type efficiencies. In contrast to wild-type sporozoites that invade hepatocytes, grow, and generate merozoites within 48 hours, the mutant sporozoites started to develop and then stopped.
There are differences in growth and development between uis3 − GAS and their RAS predecessors: RAS are thought to persist within hepatocytes developing very slowly (12, 13), whereas GAS-infected hepatocytes disappear within 24 hours after infection (14) . An extensive immunization/challenge study in mice demonstrated that 100% sterile protective immunity effective for at least 1 month could be generated in mice injected with uis3 − GAS sporozoites using various prime-boost protocols (the second boost was essential for full protection). Because there is an ortholog of uis3 in P. falciparum (PF13_0012), it may be possible to genetically engineer a P. falciparum GAS that could be used in a human vaccine.
So why is the demonstration of GASinduced protective immunity in rodents such a noteworthy advance? The first point is reproducibility. The RAS vaccine relies on irradiation of isolated sporozoites or whole infected mosquitoes with precisely the right dose of radiation-too little and the sporozoites remain fully competent to produce a complete infection; too much, and the sporozoites die and are unable to invade a liver cell and induce a protective immune response. In principle, GAS-based vaccination removes this uncertainty, offering a standardized, reproducibly attenuated parasite. But having cleared this hurdle, there are still subsequent problems with the preparation and delivery of a GAS-based vaccine.
Currently, the only way to generate GAS (or RAS) is by using infected mosquitoes. Although the parasites can be isolated from the insect for intravenous administration, there are questions about purity. In addition, even if GAS vaccination provoked longterm immunity in humans, it is inconceivable that sufficient numbers of GAS could be produced by insectaries to immunize the The fate of normal and attenuated malaria sporozoites in the host liver. A malaria infection is initiated by injection into the host blood of sporozoites by a female anopheline mosquito as she takes a blood meal. The sporozoites must migrate to the liver and colonize hepatocytes in order for the infection to progress. This involves traversal of resident macrophages (Kupffer cells) lining the liver's blood vessels and passage through a number of hepatocytes before invading a hepatocyte and beginning to develop. The sporozoite differentiates, grows, and multiplies within a vacuole in the host hepatocyte, giving rise to thousands of merozoites. These are released into the bloodstream where they invade red blood cells, initiating the erythrocytic stage of the disease. Sporozoites attenuated by irradiation (RAS) or by genetic manipulation (GAS) also transit through Kupffer cells and hepatocytes before invading liver cells. RAS undergo growth arrest but the infected hepatocytes remain intact, leading to the generation of a protective immune response involving B cells that attack free sporozoites and T cells that recognize infected hepatocytes. The intracellular development of GAS is different from that of RAS, as GAS-infected hepatocytes in culture disappear 24 hours after infection; the GAS-induced immune response may also be different.
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Moreover, we do not yet understand the mechanism of the protective immune response, the nature of the defect in uis3 − GAS, and the role of UIS3 in the intact parasite. Clearly, uis3 − GAS appear to behave differently in cultured hepatocytes than do their RAS counterparts. The possibility that the immune responses provoked by GAS and RAS are distinct is exciting and requires further investigation. The wildtype sporozoite prevents apoptosis of host liver cells that would otherwise result in destruction of the parasite (13) . The behavior of uis3 − GAS suggests that some colonized host cells do undergo apoptosis, and indeed evidence from our laboratories with a different gene-deficient GAS indicates that this is the case (15) . The possible deleterious consequences to the host of localized hepatocyte apoptosis awaits evaluation. It should also be remembered that many individuals receiving a GAS vaccine are likely to be immunocompromisedthus, the potential for breakthrough infection with a GAS vaccine must be thoroughly assessed.
Despite this daunting list, the Mueller et al. work is the first concrete demonstration, since the introduction of RAS, that full sterilizing immunity against malaria infection can be achieved. P. falciparum is amenable to genetic engineering and it should not be too difficult to produce a nonreverting uis3 − P. falciparum strain, which would enable a phase I efficacy trial in humans to begin soon. Vaccinating with attenuated infectious agents is as old as vaccination itself, and GAS is merely a new take on the old RAS concept. There is at least one other gene that generates a GAS phenotype when deleted from the wild-type parasite (15) , and surely others will be found. GAS vaccine efficacy and safety could be improved by developing more complex GAS strains that lack multiple genes in a single parasite or that have a "GAS mix" containing sporozoites each with a different single-gene deletion. Each form of GAS must be evaluated for its immunization potential and the best one, or combination, taken forward to human trials. Finally, the availability of attenuated blood-stage Plasmodium parasites indicates that an attenuated whole organism approach to malaria vaccination may be applicable to other stages of the life cycle of this vicious parasite.
I
n a tradition that originated in Babylon 4000 years ago, millions of us make New Year's resolutions. Such resolutions are often to lose weight by exercising more and eating less. No doubt, before January is out, most of us who swore to take a daily walk and pass up that extra snack have slunk back to our old habits. On page 584 of this issue, Levine et al. (1) suggest an alternative strategy for weight control. They offer evidence that differences in postural habits account for variations in body weight between the lean and the mildly obese. They propose that fidgeting, may be an unusual method of weight control.
Six years ago, Levine and co-workers introduced to Science readers the acronym NEAT, which stands for non-exercise activity thermogenesis (2) . NEAT, we were told, is the energy expended by physical activities other than planned exercise-sitting, standing, walking, talking, fidgeting, etc. In their original study, Levine's group reported that equally overfed volunteers gained different amounts of weight, a difference that they explained by an individual's propensity for NEAT (2) . Now, in a sequel to this work, Levine et al. attempt to pin down the source of NEAT that accounts for this difference in energy economy (1) . These investigators outfitted self-proclaimed "couch potatoes," both lean and mildly obese, with arrays of inclinometers and triaxial accelerometers that continuously measured body posture and movements for 10 days. The authors' main observation is that obese individuals remained seated for about 2.5 hours per day longer than the lean "couch potatoes," for an average savings of about 350 kcal/day in energy expenditure (see the figure). As this energy saving was not matched by a similar decrease in energy intake, Levine et al. calculate that this economy in energy expenditure would be sufficient for weight gain in the mildly obese.
In an attempt to determine whether this economy of motion is the cause or the consequence of obesity, Levine et al. repeated the study. This time, however, obese participants were put on a diet for 2 months and the lean ones were overfed for 2 months, resulting in a loss of 8 kg and a gain of 4 kg, respectively. Although these perturbations were small in magnitude and short in duration, both the lean and obese maintained their original posture measurements. This suggests that sedentary habits are biological rather than environmentally determined.
Obesity has reached epidemic proportions in developed societies, and billions of dollars are spent on diets and health clubs in a failing effort to control weight. Weight gain is a dynamic process that results from a longterm sustained imbalance between energy intake and energy expenditure. The spectacular increase in the prevalence of obesity over the past four decades seems to indicate that environment, rather than biology, drives the epidemic (3). At present, more than twothirds of Americans are overweight and 25% are obese, and it is expected that the prevalence of obesity in the United States will reach 40% in 2010-and the rest of the world is rapidly catching up.
Although humans have evolved thrifty mechanisms to defend energy stores during times of privation, apparently we have a much harder time preventing the storage of excess energy in times of affluence. Since the Second World War, the food industry has mass-produced increasingly palatable foods (rich in fat and refined carbohydrates) that are easily accessible and inexpensive. This has promoted excessive food intake, discouraged physical activity, and promoted obesity and its related diseases, such as diabetes, dyslipidemia, and cardiovascular disease.
The major culprit, however, is still not entirely clear: Is it increased food intake or decreased physical activity? Population data from Britain suggest that despite a doubling of the prevalence of obesity in the 1980s, the average energy intake actually declined over this period. This suggests that the adoption of a modern inactive life style is at least as important as diet in the etiology of obesity (4, 5) . In this regard, it PHYSIOLOGY A NEAT Way to Control Weight?
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